P30 CA23074/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1998	1
1999	1
2002	1
2003	2
2004	1
2005	2
2006	2
2007	1
2008	4
2009	7
2010	5
2011	5
2012	5
2013	5
2014	5
2015	5
2016	1
2022	1
2024	0

1

Recent development of anticancer therapeutics targeting Akt.

Morrow JK, Du-Cuny L, Chen L, Meuillet EJ, Mash EA, Powis G, Zhang S. Morrow JK, et al. Recent Pat Anticancer Drug Discov. 2011 Jan;6(1):146-59. doi: 10.2174/157489211793980079. Recent Pat Anticancer Drug Discov. 2011. PMID: 21110830 Free PMC article. Review.

2

Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis.

Li J, Fadare O, Xiang L, Kong B, Zheng W. Li J, et al. J Hematol Oncol. 2012 Mar 9;5:8. doi: 10.1186/1756-8722-5-8. J Hematol Oncol. 2012. PMID: 22405464 Free PMC article. Review.

3

Endometrial glandular dysplasia and endometrial intraepithelial neoplasia.

Yi X, Zheng W. Yi X, et al. Curr Opin Obstet Gynecol. 2008 Feb;20(1):20-5. doi: 10.1097/GCO.0b013e3282f2fd50. Curr Opin Obstet Gynecol. 2008. PMID: 18197001 Review.

4

The laminin binding integrin alpha6beta1 in prostate cancer perineural invasion.

Sroka IC, Anderson TA, McDaniel KM, Nagle RB, Gretzer MB, Cress AE. Sroka IC, et al. J Cell Physiol. 2010 Aug;224(2):283-8. doi: 10.1002/jcp.22149. J Cell Physiol. 2010. PMID: 20432448 Free PMC article. Review.

5

Show me your license, please: deregulation of centriole duplication mechanisms that promote amplification.

Brownlee CW, Rogers GC. Brownlee CW, et al. Cell Mol Life Sci. 2013 Mar;70(6):1021-34. doi: 10.1007/s00018-012-1102-6. Epub 2012 Aug 15. Cell Mol Life Sci. 2013. PMID: 22892665 Free PMC article. Review.

6

Tubal origin of 'ovarian' low-grade serous carcinoma.

Li J, Abushahin N, Pang S, Xiang L, Chambers SK, Fadare O, Kong B, Zheng W. Li J, et al. Mod Pathol. 2011 Nov;24(11):1488-99. doi: 10.1038/modpathol.2011.106. Epub 2011 Jun 24. Mod Pathol. 2011. PMID: 21701538 Free article.

7

GLUT3/SLC2A3 Is an Endogenous Marker of Hypoxia in Prostate Cancer Cell Lines and Patient-Derived Xenograft Tumors.

Ryniawec JM, Coope MR, Loertscher E, Bageerathan V, de Oliveira Pessoa D, Warfel NA, Cress AE, Padi M, Rogers GC. Ryniawec JM, et al. Diagnostics (Basel). 2022 Mar 10;12(3):676. doi: 10.3390/diagnostics12030676. Diagnostics (Basel). 2022. PMID: 35328229 Free PMC article.

8

IMP3 as a cytoplasmic biomarker for early serous tubal carcinogenesis.

Wang Y, Li L, Wang Y, Yuan Z, Zhang W, Hatch KD, Zheng W. Wang Y, et al. J Exp Clin Cancer Res. 2014 Jul 20;33(1):60. doi: 10.1186/s13046-014-0060-2. J Exp Clin Cancer Res. 2014. PMID: 25038792 Free PMC article.

9

Secretory cell expansion with aging: risk for pelvic serous carcinogenesis.

Li J, Ning Y, Abushahin N, Yuan Z, Wang Y, Wang Y, Yuan B, Cragun JM, Chambers SK, Hatch K, Kong B, Zheng W. Li J, et al. Gynecol Oncol. 2013 Dec;131(3):555-60. doi: 10.1016/j.ygyno.2013.09.018. Epub 2013 Sep 20. Gynecol Oncol. 2013. PMID: 24060413

10

Preparation of Drosophila S2 cells for light microscopy.

Buster DW, Nye J, Klebba JE, Rogers GC. Buster DW, et al. J Vis Exp. 2010 Jun 3;(40):1982. doi: 10.3791/1982. J Vis Exp. 2010. PMID: 20543772 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

51 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year